English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 29 Help

Selected(0)Clear Items/Page:    Sort:
TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response Journal article
Zheng, Mengqi, Zhai, Yunjiao, Yu, Yanbo, Shen, Jing, Chu, Shuzheng, Focaccia, Enrico, Tian, Wenyu, Wang, Sui, Liu, Xuesong, Yuan, Xi, Wang, Yue, Li, Lixiang, Feng, Bingcheng, Li, Zhen, Guo, Xiaohuan, Qiu, Ju, Zhang, Cuijuan, Hou, Jiajie, Sun, Yiyuan, Yang, Xiaoyun, Zuo, Xiuli, Heikenwalder, Mathias, Li, Yanqing, Yuan, Detian, Li, Shiyang. TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response[J]. Cell Metabolism, 2024, 36(9), 2086-2103.
Authors:  Zheng, Mengqi;  Zhai, Yunjiao;  Yu, Yanbo;  Shen, Jing;  Chu, Shuzheng; et al.
Favorite | TC[WOS]:1 TC[Scopus]:3  IF:27.7/31.2 | Submit date：2024/08/05
Bile Acid  Detoxification  Infliximab  Tumor Necrosis Factor  Ulcerative Colitis  
TNFR2 deficiency impairs the growth of mouse colon cancer Journal article
Li,Ping, Yang,Yang, Yang,Xinyu, Wang,Yifei, Chou,Chon Kit, Jiang,Mengmeng, Zheng,Jingbin, Chen,Fengyang, Chen,Xin*. TNFR2 deficiency impairs the growth of mouse colon cancer[J]. International Journal of Biological Sciences, 2023, 19(4), 1024-1035.
Authors:  Li,Ping;  Yang,Yang;  Yang,Xinyu;  Wang,Yifei;  Chou,Chon Kit; et al.
Favorite | TC[WOS]:8 TC[Scopus]:7  IF:8.2/8.3 | Submit date：2023/08/03
Tumor Necrosis Factor (Tnf)  Tumor Necrosis Factor Receptor Type Ii (Tnfr2)  Colon Cancer  Cancer Immunotherapy  
The therapeutic effect of tacrolimus in a mouse psoriatic model is associated with the induction of myeloid-derived suppressor cells Journal article
Shaokui Chen, Ping Liao, Long Xi, Yang Yang, Wenzhong Wu, Md Sahidul Islam, Zibei Lin, Ying Zheng, XIN CHEN*. The therapeutic effect of tacrolimus in a mouse psoriatic model is associated with the induction of myeloid-derived suppressor cells[J]. Rheumatology and Immunology Research, 2022.
Authors:  Shaokui Chen;  Ping Liao;  Long Xi;  Yang Yang;  Wenzhong Wu; et al.
Favorite | TC[WOS]:2 TC[Scopus]:1 | Submit date：2023/08/31
Myeloid-derived Suppressor Cells  Psoriasis  Tacrolimus  Tumor Necrosis Factor Receptor Type 2  
Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4+Foxp3+ regulatory T cells Journal article
Chen, Shaokui, Li, Ruixin, Chen, Yibo, Chou, Chon Kit, Zhang, Zhexuan, Yang, Yang, Liao, Ping, Wang, Qingqing, Chen, Xin*. Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4+Foxp3+ regulatory T cells[J]. Biomedicine and Pharmacotherapy, 2022, 151, 113187.
Authors:  Chen, Shaokui;  Li, Ruixin;  Chen, Yibo;  Chou, Chon Kit;  Zhang, Zhexuan; et al.
Favorite | TC[WOS]:9 TC[Scopus]:11  IF:6.9/6.8 | Submit date：2022/08/02
Cancer Immunotherapy  cd4+foxp3+ Regulatory t Cells  Cpg Oligodeoxynucleotide  Scutellarin  Tumor Necrosis Factor  Tumor Necrosis Factor Receptor Ii  
ANKRD13a controls early cell-death checkpoint by interacting with RIP1 independent of NF-κB Journal article
Won, Minho, Park, Kyeong Ah, Kim, Sup, Ju, Eunjin, Ko, Youngbok, Yoo, Heonjong, Ro, Hyunju, Lee, Jaeseob, Oh, Junseo, Lee, Eun Gyo, Kim, Sang Yean, Nam, Suk Woo, Shen, Han Ming, Yeo, Min Kyung, Kim, Jin Man, Hur, Gang Min. ANKRD13a controls early cell-death checkpoint by interacting with RIP1 independent of NF-κB[J]. Cell Death and Differentiation, 2022, 29(6), 1152-1163.
Authors:  Won, Minho;  Park, Kyeong Ah;  Kim, Sup;  Ju, Eunjin;  Ko, Youngbok; et al.
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:13.7/13.7 | Submit date：2022/05/13
Tumor-necrosis-factor  Ubiquitin-binding  Tnf  Activation  Phosphorylation  Inflammation  Apoptosis  Protein  Cancer  Polyubiquitination  
Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas Journal article
Li, Ping, Chen, Fengyang, Zheng, Jingbin, Yang, Yang, Li, Yuan, Wang, Yifei, Chen, Xin*. Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas[J]. Cancer Biology and Medicine, 2021, 18(4), 1010-1020.
Authors:  Li, Ping;  Chen, Fengyang;  Zheng, Jingbin;  Yang, Yang;  Li, Yuan; et al.
Favorite | TC[WOS]:8 TC[Scopus]:7  IF:5.6/5.9 | Submit date：2021/12/08
Bleomycin  Cyclophosphamide  Tnfr2  Tregs  Tumor Necrosis Factor  
Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis Journal article
Ye, L., Peng, W., Niu, Y., Xiang, X., Wei, X., Wang, Z., Wang, X., Zhang, Z., Chen, X.*, Zhou, Q.. Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis[J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 1647-1647.
Authors:  Ye, L.;  Peng, W.;  Niu, Y.;  Xiang, X.;  Wei, X.; et al.
Favorite |  | Submit date：2022/08/30
Tumor Necrosis Factor Receptor Type 2 (Tnfr2)  Regulatory t Cells (Tregs)  Malignant Pleural Effusion (Mpe)  
A profile of TNFR2+ regulatory T cells and CD103+ dendritic cells in the peripheral blood of patients with asthma Journal article
Azid,Nor Azrini, Ahmad,Suhana, Boer,Jennifer C., Al-Hatamleh,Mohammad A.I., Mohammad,Nurashikin, Mohd Ashari,Noor Suryani, Tan,Hern Tze, Chen,Xin, Plebanski,Magdalena, Mohamud,Rohimah. A profile of TNFR2+ regulatory T cells and CD103+ dendritic cells in the peripheral blood of patients with asthma[J]. HUMAN IMMUNOLOGY, 2020, 81(10-11), 634-643.
Authors:  Azid,Nor Azrini;  Ahmad,Suhana;  Boer,Jennifer C.;  Al-Hatamleh,Mohammad A.I.;  Mohammad,Nurashikin; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.1/2.3 | Submit date：2021/03/01
Asthma  Cd103  Dendritic Cells  Tregs  Tumor Necrosis Factor Receptor 2 (Tnfr2)  
Preferential Expansion of CD4+Foxp3+ Regulatory T Cells (Tregs) In Vitro by Tumor Necrosis Factor Book chapter
出自: T-Cell Receptor Signaling:Humana, New York, NY, 2020, 页码:71-78
Authors:  Chon-Kit Chou;  Xin Chen
Favorite | TC[WOS]:1 TC[Scopus]:1 | Submit date：2021/03/01
Cd4++++ Foxp3++++ Regulatory t Cells (Tregs)  Cfse Cell Division Assay  Flow Cytometry  Selective Expansion  Tnf Receptor 2 (Tnfr2)  Tumor Necrosis Factor (Tnf)  
TNFR2-expressing CD4(+) Foxp3(+) regulatory T cells in cancer immunology and immunotherapy Book chapter
出自: Progress in Molecular Biology and Translational Science, CA:Elsevier, 2019, 页码:101-117
Authors:  Jiang He;  Ruixin Li;  Yibo Chen;  Yuanjia Hu;  Xin Chen
Favorite | TC[WOS]:16 TC[Scopus]:16 | Submit date：2019/05/08
Regulatory t Cells  Tumor Necrosis Factor  Tumor Necrosis Factor Receptor Type 2  Cancer  Immunotherapy